Search results for "Gastric bypass"

showing 10 items of 30 documents

Optimized In Silico Modeling of Drug Absorption after Gastric Bypass: The Case of Metformin

2021

Bariatric surgery is an effective treatment for severe obesity and related comorbidities, such as type II diabetes. Gastric bypass surgery shortens the length of the intestine, possibly leading to altered drug absorption. Metformin, a first-line treatment for type II diabetes, has permeability-dependent drug absorption, which may be sensitive to intestinal anatomic changes during bypass surgery, including Roux-en-Y gastric bypass (RYGB). Previous computer simulation data indicate increased metformin absorption after RYGB. In this study, we experimentally determined the region-dependent permeability of metformin, using the rat single-pass intestinal perfusion method (SPIP), which we then imp…

Absorption (pharmacology)obesitymedicine.medical_specialtyRoux-en-Y gastric bypassbariatric surgeryUrologyPharmaceutical Sciencemedicine.disease_causeArticleJejunumGastroPlusTMPharmacy and materia medicaIn vivomedicineGastroPlus<sup>TM</sup>Intestinal permeabilityintestinal permeabilitybusiness.industryGastric bypass surgerynutritional and metabolic diseasesmedicine.diseaseMetforminRS1-441program simulationmedicine.anatomical_structuresegmental-dependent absorptionBypass surgeryDuodenummetforminbusinessmedicine.drugPharmaceutics
researchProduct

Standard vs Distal Roux-en-Y Gastric Bypass in Patients With Body Mass Index 50 to 60: A Double-blind, Randomized Clinical Trial.

2016

Up to one-third of patients undergoing bariatric surgery have a body mass index (BMI) of more than 50. Following standard gastric bypass, many of these patients still have a BMI greater than 40 after peak weight loss.To assess the efficacy and safety of standard gastric bypass vs distal gastric bypass in patients with a BMI of 50 to 60.Double-blind, randomized clinical parallel-group trial at 2 tertiary care centers in Norway (Oslo University Hospital and Vestfold Hospital Trust) between May 2011 and April 2013. The study included 113 patients with a BMI of 50 to 60 aged 20 to 60 years. The 2-year follow-up was completed in May 2015.Standard gastric bypass (alimentary limb, 150 cm) and dist…

AdultBlood GlucoseDiarrheaMalemedicine.medical_specialtyGastric Bypass030209 endocrinology & metabolismGastroenterologyProtein-Energy Malnutritionlaw.inventionBody Mass Index03 medical and health sciencesYoung Adult0302 clinical medicineRandomized controlled trialQuality of lifeDouble-Blind MethodlawWeight lossDiabetes mellitusInternal medicineWeight LossmedicineHumans030212 general & internal medicineAdverse effectGlycated HemoglobinSleep Apnea Obstructivebusiness.industryHyperparathyroidismCholesterol LDLMiddle Agedmedicine.diseaseRoux-en-Y anastomosisObesitySurgeryObesity MorbidDiabetes Mellitus Type 2HypertensionQuality of LifeSurgeryFemalemedicine.symptombusinessBody mass indexFollow-Up StudiesJAMA surgery
researchProduct

Vertical Banded Gastroplasty Converted to Roux-en-Y Gastric Bypass: Little Impact on Nutritional Status after 5-Year Follow-up

2004

Background: Conversion to a Roux-en-Y gastric bypass (RYGBP) has been advocated after the failure of vertical banded gastroplasty (VBG). The aim of this study was to analyze the differences in anthropometric and nutritional parameters between patients with VBG and those converted to RYGBP. Methods: 45 patients initially underwent VBG. 22 of these patients have maintained this operation for more than 5 years (Group A) and 23 have been converted to RYGBP (Group B), after 2 years of follow-up. We analyzed anthropometric and nutritional parameters (macronutrients,micronutrients and lipid profile), and postoperative morbidity after both procedures. Data were recorded before the first operation a…

Malemedicine.medical_specialtyGastroplastyEndocrinology Diabetes and MetabolismGastric BypassNutritional StatusWeight LossHumansMedicinePostoperative PeriodTreatment FailureVitamin B12Nutrition and Dieteticsmedicine.diagnostic_testbusiness.industryMortality rateTransferrinNutritional statusAnthropometryMicronutrientRoux-en-Y anastomosisSurgeryBanded gastroplastyVitamin B 12FemaleSurgerybusinessLipid profileFollow-Up StudiesObesity Surgery
researchProduct

Impaired oral absorption of methylphenidate after Roux-en-Y gastric bypass

2017

The anatomic and physiologic changes in the gastrointestinal (GI) tract after bariatric surgery may significantly affect the pharmacokinetics of medications taken by the patients for various reasons. Unfortunately, there is little information regarding changes in drug absorption after bariatric surgeries, limiting the ability of medical professionals to produce clear recommendations on what changes should be made to the formulations and dosing regimens of drugs after bariatric surgery. In this article, we report and analyze a case of 52-year-old male patient with morbid obesity and attention-deficit/hyperactivity disorder (ADHD) who experienced lack of methylphenidate efficacy after Roux en…

MaleDrugmedicine.medical_specialtyTransdermal patchmedia_common.quotation_subjectGastric BypassAdministration Oral03 medical and health sciences0302 clinical medicinePharmacokinetics0502 economics and businessmedicineHumans030212 general & internal medicineDosingmedia_commonMethylphenidatebusiness.industry05 social sciencesMiddle Agedmedicine.diseaseObesityRoux-en-Y anastomosisObesity MorbidSurgeryAttention Deficit Disorder with HyperactivityGastrointestinal AbsorptionAnesthesiaToxicityMethylphenidateCentral Nervous System Stimulants050211 marketingSurgerybusinessmedicine.drugSurgery for Obesity and Related Diseases
researchProduct

Revisional bariatric surgery due to failure of the initial technique: 25 years of experience in a specialized Unit of Obesity Surgery in Spain.

2019

Abstract Objectives To evaluate the effectiveness of conversion surgery in a bariatric surgery unit with 25 years of experience. Method Retrospective observational study of patients with type II obesity or higher who were reoperated by means of conversion surgery due to weight regain, residual body mass index (BMI) >35 kg/m2 or Results A total of 112 patients were included, with a mean age of 40.2 years, who initially underwent vertical banded gastroplasty (VBG) (32.1%), gastric banding (GB) (23.2%), Roux-en-Y gastric bypass (RYGB) (21.4%) and sleeve gastrectomy (SG) (23.2%). The conversion techniques, with a median time between the two surgeries of 70 months, included: RYGB, SG, one-anasto…

AdultMaleReoperationmedicine.medical_specialtySleeve gastrectomyTime FactorsGastroplastymedicine.medical_treatmentGastric BypassAftercareBariatric SurgeryComorbidity030230 surgeryWeight Gain03 medical and health sciences0302 clinical medicinePostoperative ComplicationsWeight lossGastrectomyWeight LossMedicineHumansMass indexTreatment FailurePerioperative PeriodBiliopancreatic DiversionRetrospective StudiesAnthropometrybusiness.industryMortality rateAnastomosis SurgicalGeneral EngineeringRetrospective cohort studyPerioperativeMiddle Agedmedicine.diseaseBiliopancreatic DiversionObesitySurgeryObesity MorbidSpainFemalemedicine.symptombusinessCirugia espanola
researchProduct

Laparoscopic gastric banding as a universal method for the treatment of patients with morbid obesity.

2004

Introduction: This study analyzed the influence of potentially negative predictors such as sweet-eating behavior, super-obesity, social and psychological status, family and education situation, intake of sedative drugs, and the distance between hospital and home on the outcome of laparoscopic adjustable gastric banding (LAGB). Methods: 77 women and 29 men with mean age 40.6 years (28-47) underwent LAGB. Preoperative mean body weight was 146 kg (99-179), and mean BMI was 48.1 kg/m 2 (36.4-73.5). The influence of the above-mentioned potentially negative predictors on weight loss was the primary end point. Results: Mean follow-up was 44.6 ′ 19.7 months. Follow-up was possible in all but 6 pati…

AdultMalemedicine.medical_specialtyGastroplastyGastric bandingmedicine.drug_classEndocrinology Diabetes and MetabolismGastric bypassMorbid obesityWeight lossmedicineClinical endpointHumansUnivariate analysisNutrition and Dieteticsbusiness.industryPatient SelectionMiddle AgedSurgeryObesity MorbidTreatment OutcomeSedativeSurgeryFemaleLaparoscopymedicine.symptombusinessLaparoscopic adjustable gastric bandingObesity surgery
researchProduct

Adipositaschirurgie bei monogenetisch bedingter Adipositas

2007

Surgical treatment of patients suffering from monogenetic forms of morbid obesity is considered to be the poorest investigated theme in bariatric surgery. This review article presents aspects of genetic disorders in morbid obesity as well as some aspects of surgical treatment in patients with monogenetic forms of morbid obesity (Prader-Willi-Syndrome). Gastric restrictive procedures such as vertical banded gastroplasty or adjustable gastric banding as well as malabsorptive and mix procedures such as biliopancreatic diversion or Roux-en-Y gastric bypass are used for treatment, similar to polygenetic forms of morbid obesity. Until to now there is no evidence-based data because of the small nu…

medicine.medical_specialtybusiness.industryGeneral surgeryGastric bypassObesity SurgerySurgical proceduresSurgeryReview articleBanded gastroplastymedicineSurgeryIn patientSurgical treatmentbusinessBiliopancreatic DiversionZentralblatt für Chirurgie
researchProduct

Taste for fat: the 6th taste modality

2016

IF 4.066; International audience

Vasoactive-Intestinal-PeptideBud Cells[ SDV.MHEP.PHY ] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]2-Bottle Choice Test[SDV.MHEP.PHY] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]Obesity-Resistant RatsLong-Chain FattyAcid Transporter FatGlucagon-Like Peptide-1Gastric Bypass-SurgeryReceptor-CellsSweet Taste
researchProduct

Outcome of esophageal function and 24-hour esophageal pH monitoring after vertical banded gastroplasty and Roux-en-Y gastric bypass.

2004

Background: One of the co-morbidities frequently associated with morbid obesity is gastro-esophageal reflux disease (GERD), present in >50 % of morbidly obese individuals. We compared the anti-reflux effect of vertical banded gastroplasty (VBG) and Roux-en-Y gastric bypass (RYGBP), and their effect on esophageal function. Methods: 10 patients underwent VBG and 40 patients underwent RYGBP. Anthropometric parameters, symptomatology of GERD, esophageal manometry (EM), isotopic esophageal emptying (IEE) and 24hr esophageal pH monitoring were recorded in all patients preoperatively, and at 3 months and 1 year postoperatively. Results: Preoperatively, there was a high prevalence of GERD, symptoma…

AdultMalemedicine.medical_specialtyGastroplastyEndocrinology Diabetes and MetabolismGastric BypassAnastomosisGastroenterologyEsophagusWeight lossInternal medicinemedicineHumansProspective StudiesProspective cohort studyNutrition and Dieteticsmedicine.diagnostic_testbusiness.industryRefluxAnastomosis Roux-en-YHydrogen-Ion Concentrationmedicine.diseaseRoux-en-Y anastomosisDysphagiadigestive system diseasesSurgeryObesity MorbidDiagnostic Techniques Digestive SystemTreatment OutcomeGERDGastroesophageal RefluxSurgeryFemalemedicine.symptomEsophageal pH monitoringbusinessObesity surgery
researchProduct

Taste of Fat: A Sixth Taste Modality?

2015

International audience; An attraction for palatable foods rich in lipids is shared by rodents and humans. Over the last decade, the mechanisms responsible for this specific eating behavior have been actively studied, and compelling evidence implicates a taste component in the orosensory detection of dietary lipids [i.e., long-chain fatty acids (LCFA)], in addition to textural, olfactory, and postingestive cues. The interactions between LCFA and specific receptors in taste bud cells (TBC) elicit physiological changes that affect both food intake and digestive functions. After a short overview of the gustatory pathway, this review brings together the key findings consistent with the existence…

0301 basic medicineFood intakeTastePhysiologyLong-Chain FattyAcid Transporter FatGlucagon-Like Peptide-1ReviewBiologyReceptors G-Protein-CoupledFood Preferences03 medical and health sciencesBud CellsRisk Factors2-Bottle Choice TestPhysiology (medical)Obesity-Resistant RatsAnimalsHumansGastric Bypass-SurgeryObesityGustatory pathwayTaste Bud CellsMolecular BiologyModality (semiotics)[ SDV.MHEP.PHY ] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]Fatty AcidsTaste PerceptionFeeding BehaviorGeneral MedicineTaste BudsDietary FatsSweet TasteVasoactive-Intestinal-Peptide030104 developmental biologyOverconsumptionBiochemistryTasteEating behaviorlipids (amino acids peptides and proteins)Digestive functionsReceptor-CellsNeuroscienceSignal Transduction
researchProduct